Diagnostic services market is expected to grow with a CAGR of 3% during the forecast period of 2018 to 2025.

Market Overview:

Diagnosis is a crucial process in healthcare industry, as proper diagnosis can prevent the occurrence of serious health issues. The diagnostic services market is anticipated to grow with an impressive growth rate, owing to the increasing awareness among the people regarding early and proper diagnosis of diseases & ailments. The demand for diagnosis services is surging throughout the globe due to the rise in number of geriatric individuals, increasing investment in healthcare sector, and surging deployment of private-public projects. In the current scenario, the market is dominated by unorganized sector due to the absence of stringent rules and regulations in the industry. However, the market is expected to become more organized during the upcoming years owing to the increasing number of consolidations and convergence of small players into franchise of prominent established ones. The global diagnostic services market is witnessing an escalating trend of Public Private Partnership (PPP). For instance, Krsnaa Diagnostics and SRL have opted for the PPP business model and are keen to proceed further in the market, with the same business model. In terms of region, Asia-Pacific is expected to offer lucrative opportunities to the market players active in the regional diagnostic services market due to the growing medical tourism industry in the region and improvements in healthcare infrastructures. However, the presence of inadequate regulations regarding the quality of lab & its equipment, monitoring of medical processes, skills & qualification of healthcare professionals is expected to create hurdles in the growth of diagnostic services market. The report provides detailed qualitative and quantitative analysis of the diagnostic services market. Market size and forecast in terms of value has been provided for the period - (2017 â€“ 2025) for the segments namely service type, disease, business model, and service provider in each of the major regions.

Diagnostic Services Market Segmentation

By Service Type â€¢Â Â Â Pathology â€¢Â Â Â Radiology & Imaging â€¢Â Â Â Others (nuclear medicine and laboratory medicine) By Disease â€¢Â Â Â Cardiovascular Diseases â€¢Â Â Â Cancer â€¢Â Â Â Malaria â€¢Â Â Â Tuberculosis â€¢Â Â Â Diabetes Mellitus â€¢Â Â Â HIV/AIDS â€¢Â Â Â Others By Business Model â€¢Â Â Â Public Private Partnership (PPP) â€¢Â Â Â Single Specialty Model (SSM) â€¢Â Â Â Others By Service Provider â€¢Â Â Â Hospitals â€¢Â Â Â Clinics â€¢Â Â Â Others By Geography â€¢Â Â Â North America oÂ Â Â U.S. oÂ Â Â Canada oÂ Â Â Mexico â€¢Â Â Â Europe oÂ Â Â U.K. oÂ Â Â France oÂ Â Â Germany oÂ Â Â Italy oÂ Â Â Spain oÂ Â Â Rest of Europe â€¢Â Â Â Asia-Pacific oÂ Â Â China oÂ Â Â Japan oÂ Â Â India oÂ Â Â Korea oÂ Â Â Rest of APAC â€¢Â Â Â South America oÂ Â Â Brazil oÂ Â Â Rest of South America â€¢Â Â Â Rest of the World oÂ Â Â Middle East oÂ Â Â Africa

CHAPTER 1.   INTRODUCTION
1.1.   RESEARCH METHODOLOGY
1.1.1.   ERC DESK RESEARCH
1.1.2.   ERC DATA SYNTHESIS
1.1.3.   DATA VALIDATION AND MARKET FEEDBACK
1.1.4.   ERC DATA SOURCES

CHAPTER 2.   DIAGNOSTIC SERVICES MARKET OVERVIEW
2.1.   DIAGNOSTIC SERVICES MARKET INTRODUCTION
2.2.   GLOBAL DIAGNOSTIC SERVICES MARKET REVENUE AND GROWTH RATE, 2017-2025
2.2.1.   GLOBAL DIAGNOSTIC SERVICES MARKET REVENUE (MILLION USD) AND GROWTH RATE (%), (2017-2025)

CHAPTER 3.   GLOBAL DIAGNOSTIC SERVICES MARKET BY SERVICE TYPE, 2017-2025
3.1.   PATHOLOGY
3.2.   RADIOLOGY & IMAGING
3.3.   OTHERS
3.4.   GLOBAL DIAGNOSTIC SERVICES MARKET REVENUE BY SERVICE TYPE, 2017-2025
3.4.1.   GLOBAL DIAGNOSTIC SERVICES MARKET REVENUE (MILLION USD) AND SHARE (%) BY SERVICE TYPE, 2017-2025
3.4.2.   PATHOLOGY MARKET REVENUE AND GROWTH RATE, 2017-2025
3.4.3.   RADIOLOGY & IMAGING MARKET REVENUE AND GROWTH RATE, 2017-2025
3.4.4.   OTHERS MARKET REVENUE AND GROWTH RATE, 2017-2025

CHAPTER 4.   GLOBAL DIAGNOSTIC SERVICES MARKET BY DISEASE, 2017-2025
4.1.   CARDIOVASCULAR DISEASES
4.2.   CANCER
4.3.   TUBERCULOSIS
4.4.   GLOBAL DIAGNOSTIC SERVICES MARKET REVENUE BY DISEASE, 2017-2025
4.4.1.   GLOBAL DIAGNOSTIC SERVICES MARKET REVENUE (MILLION USD) AND SHARE (%) BY DISEASE, 2017-2025
4.4.2.   CARDIOVASCULAR DISEASES MARKET REVENUE AND GROWTH RATE, 2017-2025
4.4.3.   CANCER MARKET REVENUE AND GROWTH RATE, 2017-2025
4.4.4.   TUBERCULOSIS MARKET REVENUE AND GROWTH RATE, 2017-2025
Note: Similar information coverage has been provided for other disease, business model and service provider segment
CHAPTER 5.   GLOBAL DIAGNOSTIC SERVICES MARKET BY REGION, 2017-2025
5.1.   NORTH AMERICA
5.1.1.   U.S.
5.1.2.   CANADA
5.1.3.   MEXICO
5.2.   EUROPE
5.2.1.   U.K.
5.2.2.   FRANCE
5.2.3.   GERMANY
5.2.4.   ITALY
5.2.5.   SPAIN
5.2.6.   REST OF EUROPE
5.3.   ASIA PACIFIC
5.3.1.   CHINA
5.3.2.   JAPAN
5.3.3.   INDIA
5.3.4.   KOREA
5.3.5.   REST OF APAC
5.4.   SOUTH AMERICA
5.4.1.   BRAZIL
5.4.2.   REST OF SOUTH AMERICA
5.5.   REST OF THE WORLD
5.5.1.   MIDDLE EAST
5.5.2.   AFRICA
5.6.   GLOBAL DIAGNOSTIC SERVICES MARKET REVENUE BY REGION, 2017-2025
5.6.1.   GLOBAL DIAGNOSTIC SERVICES MARKET REVENUE (MILLION USD) AND SHARE (%) BY REGION, 2017-2025
5.6.2.   NORTH AMERICA MARKET REVENUE AND GROWTH RATE, 2017-2025
5.6.3.   EUROPE MARKET REVENUE AND GROWTH RATE, 2017-2025
5.6.4.   ASIA PACIFIC MARKET REVENUE AND GROWTH RATE, 2017-2025
5.6.5.   SOUTH AMERICA MARKET REVENUE AND GROWTH RATE, 2017-2025
5.6.6.   REST OF THE WORLD MARKET REVENUE AND GROWTH RATE, 2017-2025

CHAPTER 6.   MARKET DETERMINANTS
6.1.   MARKET DRIVERS
6.2.   MARKET RESTRAINTS
6.3.   MARKET OPPORTUNITIES
6.4.   MARKET DETERMINANTS RADAR CHART

CHAPTER 7.   GLOBAL DIAGNOSTIC SERVICES MARKET COMPETITION BY SERVICE PROVIDERS
7.1.   GLOBAL DIAGNOSTIC SERVICES REVENUE AND SHARE BY SERVICE PROVIDERS (2017-2025)
7.1.1.   GLOBAL DIAGNOSTIC SERVICES REVENUE (MILLION USD) AND SHARE (%) BY SERVICE PROVIDERS (2017-2025)
7.2.   DIAGNOSTIC SERVICES MARKET COMPETITIVE SITUATION AND TRENDS
7.2.1.   DIAGNOSTIC SERVICES MARKET SHARE (%) OF TOP 3 SERVICE PROVIDERS
7.2.2.   DIAGNOSTIC SERVICES MARKET SHARE (%) OF TOP 5 SERVICE PROVIDERS

CHAPTER 8.   COMPANY PROFILES
8.1.   ABOTT LABORATORIES
8.1.1.   BUSINESS OVERVIEW
8.1.2.   COMPANY BASIC INFORMATION
8.1.3.   DIAGNOSTIC SERVICES PRODUCT DETAILS
8.1.4.   ABOTT LABORATORIES DIAGNOSTIC SERVICES REVENUE AND GROSS MARGIN

8.2.   ROCHE DIAGNOSTICS
8.2.1.   BUSINESS OVERVIEW
8.2.2.   COMPANY BASIC INFORMATION
8.2.3.   DIAGNOSTIC SERVICES PRODUCT DETAILS
8.2.4.   ROCHE DIAGNOSTICS DIAGNOSTIC SERVICES REVENUE AND GROSS MARGIN

8.3.   METROPOLIS HEALTHCARE LIMITED
8.3.1.   BUSINESS OVERVIEW
8.3.2.   COMPANY BASIC INFORMATION
8.3.3.   DIAGNOSTIC SERVICES PRODUCT DETAILS
8.3.4.   METROPOLIS HEALTHCARE LIMITED DIAGNOSTIC SERVICES REVENUE AND GROSS MARGIN

8.4.   BECKMAN COULTER
8.4.1.   BUSINESS OVERVIEW
8.4.2.   COMPANY BASIC INFORMATION
8.4.3.   DIAGNOSTIC SERVICES PRODUCT DETAILS
8.4.4.   BECKMAN COULTER DIAGNOSTIC SERVICES REVENUE AND GROSS MARGIN

8.5.   SIEMENS HEALTHCARE GMBH
8.5.1.   BUSINESS OVERVIEW
8.5.2.   COMPANY BASIC INFORMATION
8.5.3.   DIAGNOSTIC SERVICES PRODUCT DETAILS
8.5.4.   SIEMENS HEALTHCARE GMBH DIAGNOSTIC SERVICES REVENUE AND GROSS MARGIN

8.6.   TOSHIBA CORPORATION
8.6.1.   BUSINESS OVERVIEW
8.6.2.   COMPANY BASIC INFORMATION
8.6.3.   DIAGNOSTIC SERVICES PRODUCT DETAILS
8.6.4.   TOSHIBA CORPORATION DIAGNOSTIC SERVICES REVENUE AND GROSS MARGIN

8.7.   KONINKLIJKE PHILIPS N.V.
8.7.1.   BUSINESS OVERVIEW
8.7.2.   COMPANY BASIC INFORMATION
8.7.3.   DIAGNOSTIC SERVICES PRODUCT DETAILS
8.7.4.   KONINKLIJKE PHILIPS N.V. DIAGNOSTIC SERVICES REVENUE AND GROSS MARGIN

8.8.   JOHNSON & JOHNSON MEDICAL DEVICES AND DIAGNOSTICS
8.8.1.   BUSINESS OVERVIEW
8.8.2.   COMPANY BASIC INFORMATION
8.8.3.   DIAGNOSTIC SERVICES PRODUCT DETAILS
8.8.4.   JOHNSON & JOHNSON MEDICAL DEVICES AND DIAGNOSTICS DIAGNOSTIC SERVICES REVENUE AND GROSS MARGIN

8.9.   GE HEALTHCARE
8.9.1.   BUSINESS OVERVIEW
8.9.2.   COMPANY BASIC INFORMATION
8.9.3.   DIAGNOSTIC SERVICES PRODUCT DETAILS
8.9.4.   GE HEALTHCARE DIAGNOSTIC SERVICES REVENUE AND GROSS MARGIN

8.10.   BIOMERIEUX
8.10.1.   BUSINESS OVERVIEW
8.10.2.   COMPANY BASIC INFORMATION
8.10.3.   DIAGNOSTIC SERVICES PRODUCT DETAILS
8.10.4.   BIOMERIEUX DIAGNOSTIC SERVICES REVENUE AND GROSS MARGIN

CHAPTER 9.   DIAGNOSTIC SERVICES MARKET VALUE CHAIN ANALYSIS
9.1.   DIAGNOSTIC SERVICES INDUSTRIAL CHAIN ANALYSIS

•   Abott Laboratories
•   Roche Diagnostics
•   Metropolis Healthcare Limited
•   Beckman Coulter
•   Siemens Healthcare GmbH
•   TOSHIBA CORPORATION
•   Koninklijke Philips N.V.
•   Johnson & Johnson Medical Devices and Diagnostics
•   GE Healthcare
•   BioMerieux
•   Hitachi Medical Corporation
•   Shimadzu Corporation
•   Fujifilm Corporation
•   Thyrocare Technologies Limited
•   Oncquest Laboratories Ltd.
•   Esaote SpA
•   Hologic Inc.

Market Overview:

Diagnostic Services Market Segmentation

Report Highlights:

CLIENTS

CORPORATE OFFICE

COMPANY

SECURE ONLINE PAYMENTS

FOLLOW US